Nitric oxide inhibits Coxsackievirus B3 replication in vitro by suppressing viral RNA and protein synthesis, providing mechanistic insights into its antiviral properties.
Answers are grounded in this paper and cite their sources.
Extends in vitro mechanistic insights into nitric oxide antiviral effects; leaves open in vivo efficacy and clinical translation.
Nitric oxide is a radical molecule with antibacterial, -parasitic, and -viral properties. We investigated the mechanism of NO inhibition of Coxsackievirus B3 (CVB3) replication in vitro by determining the effect of NO upon a single replicative cycle of CVB3 grown in HeLa cells. Transfection of inducible NO synthase cDNA into HeLa cells reduces the number of viral particles produced during a single cycle of growth. Similarly, a noncytotoxic concentration of the NO donor S-nitroso-amino-penicillamine reduces the number of viral particles in a dose-dependent manner. To explore the mechanisms by which NO exerts its antiviral effect, we assayed the attachment, replication, and translation steps of the CVB3 life cycle. NO does not affect the attachment of CVB3 to HeLa cells. However, NO inhibits CVB3 RNA synthesis, as shown by a [3H]uridine incorporation assay, reverse transcription-PCR, and Northern analysis. In addition, NO inhibits CVB3 protein synthesis, as shown by [35S]methionine protein labeling and Western blot analysis of infected cells. Thus, NO inhibits CVB3 replication in part by inhibiting viral RNA synthesis by an unknown mechanism.
No takes yet. Share an insight, caveat, or question.
Zaragoza et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: